118 related articles for article (PubMed ID: 33650810)
1. Clinical use of the modified shuttle test in children with cystic fibrosis: Is one test sufficient?
Leite LR; Queiroz KCV; da Silva FH; Coelho CC; Donadio MVF; Aquino EDS
Pediatr Pulmonol; 2021 Jun; 56(6):1550-1557. PubMed ID: 33650810
[TBL] [Abstract][Full Text] [Related]
2. Prediction of peak oxygen uptake using the modified shuttle test in children and adolescents with cystic fibrosis.
Vendrusculo FM; Heinzmann-Filho JP; Campos NE; Gheller MF; de Almeida IS; Donadio MVF
Pediatr Pulmonol; 2019 Apr; 54(4):386-392. PubMed ID: 30614221
[TBL] [Abstract][Full Text] [Related]
3. Validation of the 25 level modified shuttle test in children with cystic fibrosis.
Corda J; E Holland A; Berry CD; Westrupp N; Cox NS
Pediatr Pulmonol; 2023 Aug; 58(8):2240-2248. PubMed ID: 37144876
[TBL] [Abstract][Full Text] [Related]
4. Reliability, repeatability, and sensitivity of the modified shuttle test in adult cystic fibrosis.
Bradley J; Howard J; Wallace E; Elborn S
Chest; 2000 Jun; 117(6):1666-71. PubMed ID: 10858400
[TBL] [Abstract][Full Text] [Related]
5. Test-retest reliability, minimal detectable change and minimal clinically important differences in modified shuttle walk test in children and adolescents with cystic fibrosis.
Del Corral T; Gómez Sánchez Á; López-de-Uralde-Villanueva I
J Cyst Fibros; 2020 May; 19(3):442-448. PubMed ID: 31678012
[TBL] [Abstract][Full Text] [Related]
6. Determinants of Exercise Capacity Assessed With the Modified Shuttle Test in Individuals With Cystic Fibrosis.
Vendrusculo FM; Aquino ES; Campos NE; de Almeida IS; Heinzmann-Filho JP; Queiroz KCV; Leite LR; Donadio MVF
Respir Care; 2020 May; 65(5):643-649. PubMed ID: 32047118
[TBL] [Abstract][Full Text] [Related]
7. "Test-retest reliability and minimal detectable change in TGlittre-P test in children and adolescents with cystic fibrosis".
Scalco JC; Martins R; Almeida ACDS; Caputo F; Schivinski CIS
Disabil Rehabil; 2022 Jul; 44(14):3701-3707. PubMed ID: 33496210
[TBL] [Abstract][Full Text] [Related]
8. The modified shuttle test as a predictor of risk for hospitalization in youths with cystic fibrosis: A two-year follow-up study.
Donadio MVF; Vendrusculo FM; Campos NE; Becker NA; de Almeida IS; Queiroz KCV; Leite LR; Aquino ES
J Cyst Fibros; 2021 Jul; 20(4):648-654. PubMed ID: 33422453
[TBL] [Abstract][Full Text] [Related]
9. Validation of shuttle tests in children with cystic fibrosis.
Selvadurai HC; Cooper PJ; Meyers N; Blimkie CJ; Smith L; Mellis CM; Van Asperen PP
Pediatr Pulmonol; 2003 Feb; 35(2):133-8. PubMed ID: 12526075
[TBL] [Abstract][Full Text] [Related]
10. FUNCTIONAL PERFORMANCE IN THE MODIFIED SHUTTLE TEST IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS.
Leite LR; Queiroz KCV; Coelho CC; Vergara AA; Donadio MVF; Aquino EDS
Rev Paul Pediatr; 2021; 39():e2019322. PubMed ID: 32785464
[TBL] [Abstract][Full Text] [Related]
11. Relationship between lung function and Modified Shuttle Test performance in adult patients with cystic fibrosis: a cross-sectional, retrospective study.
Doeleman WR; Takken T; Bronsveld I; Hulzebos EH
Physiotherapy; 2016 Jun; 102(2):184-8. PubMed ID: 27101722
[TBL] [Abstract][Full Text] [Related]
12. Validity of a modified shuttle test in adult cystic fibrosis.
Bradley J; Howard J; Wallace E; Elborn S
Thorax; 1999 May; 54(5):437-9. PubMed ID: 10212110
[TBL] [Abstract][Full Text] [Related]
13. Modified shuttle test performance in hospitalized children and adolescents with cystic fibrosis.
Cox NS; Follett J; McKay KO
J Cyst Fibros; 2006 Aug; 5(3):165-70. PubMed ID: 16679070
[TBL] [Abstract][Full Text] [Related]
14. Minimal detectable change in six-minute walk test in children and adolescents with cystic fibrosis.
López-de-Uralde-Villanueva I; Sarría Visa T; Moscardó Marichalar P; Del Corral T
Disabil Rehabil; 2021 Jun; 43(11):1594-1599. PubMed ID: 31536381
[TBL] [Abstract][Full Text] [Related]
15. Ventilatory limitation and dynamic hyperinflation during exercise testing in Cystic Fibrosis.
Karapanagiotis S; Gambazza S; Brivio A; D'Abrosca F; Colombo C
Pediatr Pulmonol; 2017 Jan; 52(1):29-33. PubMed ID: 27736037
[TBL] [Abstract][Full Text] [Related]
16. Effects of a supervised, outpatient exercise and physiotherapy programme in children with cystic fibrosis.
Urquhart D; Sell Z; Dhouieb E; Bell G; Oliver S; Black R; Tallis M
Pediatr Pulmonol; 2012 Dec; 47(12):1235-41. PubMed ID: 22553169
[TBL] [Abstract][Full Text] [Related]
17. Tissue oxygenation in peripheral muscles and functional capacity in cystic fibrosis: a cross-sectional study.
Coelho CC; Aquino EDS; Diniz ALR; Santos MDS; Oliveira LC; Poeiras PTC; Pereira DAG
Exp Physiol; 2020 Sep; 105(9):1571-1578. PubMed ID: 32770583
[TBL] [Abstract][Full Text] [Related]
18. Measurement properties of the one-minute sit-to-stand test in children and adolescents with cystic fibrosis: A multicenter randomized cross-over trial.
Combret Y; Boujibar F; Gennari C; Medrinal C; Sicinski S; Bonnevie T; Gravier FE; Laurans M; Marguet C; Le Roux P; Lamia B; Prieur G; Reychler G
PLoS One; 2021; 16(2):e0246781. PubMed ID: 33577586
[TBL] [Abstract][Full Text] [Related]
19. Respiratory muscle strength in stable adolescent and adult patients with cystic fibrosis.
Dunnink MA; Doeleman WR; Trappenburg JC; de Vries WR
J Cyst Fibros; 2009 Jan; 8(1):31-6. PubMed ID: 18838310
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal assessment of exercise capacity and quality of life outcome measures in cystic fibrosis: A year-long prospective pilot study.
Bhatia R; Kaye M; Roberti-Miller A
J Eval Clin Pract; 2020 Feb; 26(1):236-241. PubMed ID: 30761692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
